X0609 4 2026-07-15 0001877184 KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS 0001877188 Webster Brian Daniel false 3933 LAKE WASHINGTON BLVD NE, SUITE 200 KIRKLAND WA 98033 true true false false See Remarks true Common Shares 2026-07-15 4 A false 176470 0.00 A 571937 D Common Shares 2026-07-15 2026-07-15 4 S false 11216 22.0105 D 560721 D Common Shares 2026-07-15 2026-07-15 4 S false 784 22.6333 D 559937 D Common Shares 2026-07-15 2026-07-15 4 S false 3000 23.9983 D 556937 D Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026. The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $21.45 to $22.44. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.45 to $23.00. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.49 to $24.10. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. President and Chief Executive Officer /s/ Brian Daniel Webster 2026-07-17